3PO, a novel nonviral gene delivery system using engineered Ad5 penton proteins

被引:34
|
作者
Medina-Kauwe, LK
Kasahara, N
Kedes, L
机构
[1] Univ So Calif, Keck Sch Med, Inst Genet Med, Los Angeles, CA 90033 USA
[2] Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, Los Angeles, CA 90033 USA
[3] Univ So Calif, Keck Sch Med, Dept Pathol, Los Angeles, CA 90033 USA
关键词
3PO; PBK10; penton; protamine; adenovirus; gene therapy;
D O I
10.1038/sj.gt.3301448
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
This study describes the development of 3PO, a nonviral, protein-based gene delivery vector which utilizes the highly evolved cell-binding, cell-entry and intracellular transport functions of the adenovirus serotype 5 (Ad5) capsid penton protein. A penton fusion protein containing a polylysine sequence was produced by recombinant methods and tested for gene delivery capability. As the protein itself is known to bind integrins through a conserved consensus motif, the penton inherently possesses the ability to bind and enter cells through receptor-mediated internalization. The ability to lyse the cellular endosome encapsulating internalized receptors is also attributed to the penton. The recombinant protein gains the additional function of DNA binding and transport with the appendage of a polylysine motif. This protein retains the ability to form pentamers and mediates delivery of a reporter gene to cultured cells. Interference by oligopeptides bearing the integrin binding motif suggests that delivery is mediated specifically through integrin receptor binding and internalization. The addition of protamine to penton-DNA complexes allows gene delivery in the presence of serum.
引用
收藏
页码:795 / 803
页数:9
相关论文
共 11 条
  • [1] 3PO, a novel nonviral gene delivery system using engineered Ad5 penton proteins
    L K Medina-Kauwe
    N Kasahara
    L Kedes
    Gene Therapy, 2001, 8 : 795 - 803
  • [2] Nonviral gene delivery to human breast cancer cells by targeted Ad5 penton proteins
    Medina-Kauwe, LK
    Maguire, M
    Kasahara, N
    Kedes, L
    GENE THERAPY, 2001, 8 (23) : 1753 - 1761
  • [3] Nonviral gene delivery to human breast cancer cells by targeted Ad5 penton proteins
    LK Medina-Kauwe
    M Maguire
    N Kasahara
    L Kedes
    Gene Therapy, 2001, 8 : 1753 - 1761
  • [4] The Ad5 fiber mediates nonviral gene transfer in the absence of the whole virus, utilizing a novel cell entry pathway
    A Rentsendorj
    H Agadjanian
    X Chen
    M Cirivello
    M Macveigh
    L Kedes
    S Hamm-Alvarez
    L K Medina-Kauwe
    Gene Therapy, 2005, 12 : 225 - 237
  • [5] The Ad5 fiber mediates nonviral gene transfer in the absence of the whole virus, utilizing a novel cell entry pathway
    Rentsendorj, A
    Agadjanian, H
    Chen, X
    Cirivello, M
    Macveigh, M
    Kedes, L
    Hamm-Alvarez, S
    Medina-Kauwe, LK
    GENE THERAPY, 2005, 12 (03) : 225 - 237
  • [6] A novel gene delivery system using urothelial tissue engineered neo-organs
    Yoo, JJ
    Atala, A
    JOURNAL OF UROLOGY, 1997, 158 (03): : 1066 - 1070
  • [7] Nonviral Gene Delivery of Growth and Differentiation Factor 5 to Human Mesenchymal Stem Cells Injected into a 3D Bovine Intervertebral Disc Organ Culture System
    Bucher, Christian
    Gazdhar, Amiq
    Benneker, Lorin M.
    Geiser, Thomas
    Gantenbein-Ritter, Benjamin
    STEM CELLS INTERNATIONAL, 2013, 2013
  • [8] Anaerobic bacteria as a delivery system for cancer gene therapy: In vitro activation of 5-fluorocytosine by genetically engineered clostridia (vol 3, pg 173, 1996)
    Fox, ME
    Lemmon, MJ
    Mauchline, ML
    Davis, TO
    Giaccia, AJ
    Minton, NP
    Brown, JM
    GENE THERAPY, 1996, 3 (08) : 741 - 741
  • [9] Gene delivery of GFP-CFTR to human airway epithelial and tracheal cells using a pseudotyped ad5 vector carrying serotype 35 fibers: Transduction efficiency, GFP-CFTR localization, functionality, and vector toxicity
    Granio, Ophelia
    Franqueville, Laure
    Henning, Petra
    Norez, Caroline
    Excoffon, Katherine J. D. Ashbourne
    Melin, Patricia
    Habib, Nagy
    Lindholm, Leif
    Becq, Frederic
    Zabner, Joseph
    Boulanger, Pierre
    Hong, Saw-See
    HUMAN GENE THERAPY, 2007, 18 (10) : 1076 - 1076
  • [10] Enhanced Prostate Cancer Gene Transfer and Therapy Using a Novel Serotype Chimera Cancer Terminator Virus (Ad.5/3-CTV)
    Azab, Belal M.
    Dash, Rupesh
    Das, Swadesh K.
    Bhutia, Sujit K.
    Sarkar, Siddik
    Shen, Xue-Ning
    Quinn, Bridget A.
    Dent, Paul
    Dmitriev, Igor P.
    Wang, Xiang-Yang
    Curiel, David T.
    Pellecchia, Maurizio
    Reed, John C.
    Sarkar, Devanand
    Fisher, Paul B.
    JOURNAL OF CELLULAR PHYSIOLOGY, 2014, 229 (01) : 34 - 43